Last Updated: September 24, 2026

Details for New Drug Application (NDA): 018604

✉ Email this page to a colleague

NDA 018604 describes ZOVIRAX, which is a drug marketed by Pharmobedient, Bausch, and Glaxosmithkline, and is included in six NDAs. It is available from three suppliers. Additional details are available on the ZOVIRAX profile page.

The generic ingredient in ZOVIRAX is acyclovir sodium. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.

Summary for 018604

Tradename:	ZOVIRAX
Applicant:	Bausch
Ingredient:	acyclovir
Patents:	0

Pharmacology for NDA: 018604

Mechanism of Action	DNA Polymerase Inhibitors

Medical Subject Heading (MeSH) Categories for 018604

Antiviral Agents

Suppliers and Packaging for NDA: 018604

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZOVIRAX	acyclovir	OINTMENT;TOPICAL	018604	NDA	Bausch Health US, LLC	0187-0993	0187-0993-95	1 TUBE in 1 CARTON (0187-0993-95) / 30 g in 1 TUBE
ZOVIRAX	acyclovir	OINTMENT;TOPICAL	018604	NDA AUTHORIZED GENERIC	ACTAVIS PHARMA, INC.	0591-1159	0591-1159-30	1 TUBE in 1 CARTON (0591-1159-30) / 30 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	OINTMENT;TOPICAL			Strength	5%
Approval Date:	Mar 29, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 018604

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	ZOVIRAX	acyclovir	OINTMENT;TOPICAL	018604-001	Mar 29, 1982	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.